DEP-Cabazitaxel

DEP-卡巴他赛

Report date: 2024/04/07 16:53:21

Base Information

Drug NameDEP-Cabazitaxel
Drug Alias NameCTX-SPL-9111卡巴他赛-树枝状大分子缀合物 CTX-SPL9111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesStarpharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStarpharma Pty Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A